.webp){kind=logo}
Introducing Our New Principal Investigator — Dr. Dimitrios Tsoukas
June 2, 2025
Introducing Our New Principal Investigator — Dr. Dimitrios Tsoukas
.png)
RegenMed is proud to announce that Dr. Dimitrios Tsoukas will act as Principal Investigator for a series of major Physicians-Owned Circles in the fast-evolving field of orthobioligics. These will be the first POCs in Greece. The initial POC Observational Protocol designed by Dr. Tsoukas will generate clinically and statistically significant datasets comparing safety and efficacy of PRP, ADSCs, and BMAC in knee osteoarthritis. His clinical surveys will not only track dosage, injection sites and other key treatment protocol information, but specific products used and delivery approaches.
The resulting well-correlated datasets will thus represent substantial value to product manufacturers, payers, researchers, AI models and other licensees. Physician investigators participating in Dr. Tsoukas’s POCs will share 85% of all such license fees.
In addition to senior positions in several orthopedic organizations such as ESSKA and ISAKOS, Dr. Tsoukas is the founder of IARMES, which includes other leading orthopedic practitioners in Europe and North America. Moreover, Dr. Tsoukas also teaches and practices in several countries outside of Greece, including Switzerland, Qatar, and the UAE. He is also an Adjunct Professor at the University of Nebraska, Lincoln. As such, RegenMed and Dr. Tsoukas expect to significantly expand international physician participation in his Circles.
Introducing Our New Principal Investigator — Dr. Dimitrios Tsoukas
June 2, 2025
RegenMed is proud to announce that Dr. Dimitrios Tsoukas will act as Principal Investigator for a series of major Physicians-Owned Circles in the fast-evolving field of orthobioligics. These will be the first POCs in Greece. The initial POC Observational Protocol designed by Dr. Tsoukas will generate clinically and statistically significant datasets comparing safety and efficacy of PRP, ADSCs, and BMAC in knee osteoarthritis. His clinical surveys will not only track dosage, injection sites and other key treatment protocol information, but specific products used and delivery approaches.
The resulting well-correlated datasets will thus represent substantial value to product manufacturers, payers, researchers, AI models and other licensees. Physician investigators participating in Dr. Tsoukas’s POCs will share 85% of all such license fees.
In addition to senior positions in several orthopedic organizations such as ESSKA and ISAKOS, Dr. Tsoukas is the founder of IARMES, which includes other leading orthopedic practitioners in Europe and North America. Moreover, Dr. Tsoukas also teaches and practices in several countries outside of Greece, including Switzerland, Qatar, and the UAE. He is also an Adjunct Professor at the University of Nebraska, Lincoln. As such, RegenMed and Dr. Tsoukas expect to significantly expand international physician participation in his Circles.
